Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912065 · ClinicalTrials.gov registry record
Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 13
- Enrollment target
NCT02912065 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 13 participants.
The verdict
NCT02912065 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02912065
The ClinicalTrials.gov registry entry for NCT02912065 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02912065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02912065 about?
NCT02912065 is a clinical study titled "Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay". A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.
What is the current status of trial NCT02912065?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-01. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02912065?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.